Not applicableLooking for participantsNCT06001281What this trial is testingPredictive Value of Soluble CD146 in Glioblastoma PatientsWho this might be right forGlioblastoma Assistance Publique Hopitaux De Marseille 55
Testing effectiveness (Phase 2)Study completedNCT00624728What this trial is testingAssessment of 18FLT PET-CT for Volume Definition of High-grade Gliomas (GLIO-TEP)Who this might be right forHigh-grade GliomaAstrocytomaGlioblastoma University Hospital, Bordeaux 21
Early research (Phase 1)Study completedNCT00694837What this trial is testingStudy With Nelfinavir and Combined Radiochemotherapy for GlioblastomaWho this might be right forGlioblastoma Maastricht Radiation Oncology 6
Testing effectiveness (Phase 2)UnknownNCT05611645What this trial is testingLow-dose Bevacizumab With HSRT vs BVZ Alone for GBM at First RecurrenceWho this might be right forGliomaRecurrent Glioma Huashan Hospital 42
Testing effectiveness (Phase 2)Ended earlyNCT01721577What this trial is testingPhase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant AstrocytomasWho this might be right forGlioblastomaGliosarcomaAnaplastic Astrocytoma+3 more Rush University Medical Center 10
Not applicableStudy completedNCT02843230What this trial is testingMonitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRIWho this might be right forGlioblastoma Massachusetts General Hospital 30
Early research (Phase 1)Study completedNCT00634231What this trial is testingA Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain TumorsWho this might be right forMalignant GliomaRecurrent Ependymoma Candel Therapeutics, Inc. 8
Testing effectiveness (Phase 2)Study completedNCT02067156What this trial is testingEfficacy, Safety and CNS Exposure of G-202 (Mipsagargin) in Patients With Recurrent or Progressive GlioblastomaWho this might be right forGlioblastoma Multiforme GenSpera, Inc. 26
Testing effectiveness (Phase 2)Study completedNCT02858895What this trial is testingConvection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive GlioblastomaWho this might be right forGlioblastomaGrade IV AstrocytomaGlioblastoma Multiforme+1 more Medicenna Therapeutics, Inc. 47
Large-scale testing (Phase 3)Ended earlyNCT03149575What this trial is testingVAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBMWho this might be right forGlioblastoma MultiformeGlioblastomaGlioma+2 more DelMar Pharmaceuticals, Inc. 2
Large-scale testing (Phase 3)Looking for participantsNCT07100730What this trial is testingStudy of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent GlioblastomaWho this might be right forNeoplastic DiseaseGlioblastomaGlioblastoma (GBM)+3 more Telix Pharmaceuticals (Innovations) Pty Limited 50
Early research (Phase 1)Active Not RecruitingNCT05241392What this trial is testingSafety and Efficacy Study of Anti-B7-H3 CAR-T Cell Therapy for Recurrent GlioblastomaWho this might be right forGlioblastoma Beijing Tiantan Hospital 30
Early research (Phase 1)Study completedNCT00720564What this trial is testingRadiation Therapy, Arsenic Trioxide, and Temozolomide in Treating Patients With Newly Diagnosed High-Grade GliomaWho this might be right forBrain and Central Nervous System Tumors City of Hope Medical Center 18
Very early researchEnded earlyNCT04825275What this trial is testingNeuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: A Phase 0 Clinical TrialWho this might be right forGlioblastomaGlioblastoma MultiformeGlioblastoma Multiforme of Brain+1 more Milton S. Hershey Medical Center 7
Testing effectiveness (Phase 2)Temporarily pausedNCT05607407What this trial is testingMethimazole in Patients With Progressive GlioblastomaWho this might be right forGlioblastomaGlioma Case Comprehensive Cancer Center 19
Testing effectiveness (Phase 2)UnknownNCT00275067What this trial is testingArsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By SurgeryWho this might be right forBrain and Central Nervous System Tumors Northwestern University 50
Testing effectiveness (Phase 2)Ended earlyNCT01205334What this trial is testingAdministration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma MultiformeWho this might be right forGlioblastoma MultiformeGBMBrain Cancer Baylor College of Medicine 2
Early research (Phase 1)Ended earlyNCT05324501What this trial is testingIntra-tumoral Administered MTX110 in Patients With Recurrent GlioblastomaWho this might be right forRecurrent Glioblastoma Biodexa Pharmaceuticals 4
Not applicableLooking for participantsNCT07552467What this trial is testingSub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant TumorsWho this might be right forPancreatic CancerBreast CancerLung Cancer+5 more Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 26
Testing effectiveness (Phase 2)Ended earlyNCT04952571What this trial is testingCombined Treatment of Camrelizumab and Bevacizumab for Adult Patients with Recurrent Glioblastoma (GBM)Who this might be right forRecurrent Glioblastoma Beijing Sanbo Brain Hospital 3